EVFM (Evofem Biosciences) Inventories, Finished Goods: $1.27 Mil (As of Mar. 2026)


What is Evofem Biosciences Inventories, Finished Goods?

Evofem Biosciences EVFM -9.09% Inventories, Finished Goods is $1.27 Mil as of Mar. 2026. The stock has 5 warning signs investors should review.

Evofem Biosciences's quarterly finished goods declined from Sep. 2025 ($0.76 Mil) to Dec. 2025 ($0.62 Mil) but then increased from Dec. 2025 ($0.62 Mil) to Mar. 2026 ($1.27 Mil).

Evofem Biosciences's annual finished goods declined from Dec. 2023 ($0.79 Mil) to Dec. 2024 ($0.25 Mil) but then increased from Dec. 2024 ($0.25 Mil) to Dec. 2025 ($0.62 Mil).

Evofem Biosciences Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Evofem Biosciences's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Evofem Biosciences Inventories, Finished Goods Chart

Evofem Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.79 0.25 0.62

Evofem Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.02 1.04 0.76 0.62 1.27

Evofem Biosciences Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of $1.27 Mil mean?
Evofem Biosciences (EVFM) has a Inventories, Finished Goods of $1.27 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Evofem Biosciences and its competitors.
Is Evofem Biosciences' Inventories, Finished Goods too high?
Evofem Biosciences' current Inventories, Finished Goods is $1.27 Mil.
How does Evofem Biosciences' Inventories, Finished Goods compare to LYRA and CLSDQ?
Evofem Biosciences' Inventories, Finished Goods of $1.27 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Biotechnology company?
A good Inventories, Finished Goods depends on the Biotechnology industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Evofem Biosciences and its competitors. Evofem Biosciences's current Inventories, Finished Goods is $1.27 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Evofem Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Evofem Biosciences (EVFM) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.01, compared to a current price of $0.01 — trading 15% below its estimated fair value. The current Inventories, Finished Goods is $1.27 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Evofem Biosciences (EVFM), the current Inventories, Finished Goods is $1.27 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Evofem Biosciences Business Description

Address 7770 Regents Road, Suite 113-618, San Diego, CA, USA, 92122
Evofem Biosciences Inc is a commercial-stage biopharmaceutical company committed to developing and commercializing products to address unmet needs in women's sexual and reproductive health. The company's product, Phexxi (lactic acid, citric acid, and potassium bitartrate), is a hormone-free, prescription vaginal gel approved in the United States for the prevention of pregnancy.